Olanzapine for Schizophrenia Improves Meds Compliance – MM1510
Schizophrenia is a chronic and disabling psychiatric disorder afflicting approximately one percent of the population world-wide with little gender differences. For patients with schizophrenia, treatment with antipsychotics is typically necessary for the long term, but persistence on treatment is often poor, resulting in frequent relapses with potentially serious consequences.
Modern Medicine – October 2015
